1. Home
  2. RGEN vs EHC Comparison

RGEN vs EHC Comparison

Compare RGEN & EHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$173.31

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Logo Encompass Health Corporation

EHC

Encompass Health Corporation

HOLD

Current Price

$107.61

Market Cap

12.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGEN
EHC
Founded
1981
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
12.4B
IPO Year
N/A
1986

Fundamental Metrics

Financial Performance
Metric
RGEN
EHC
Price
$173.31
$107.61
Analyst Decision
Buy
Strong Buy
Analyst Count
10
8
Target Price
$174.90
$141.88
AVG Volume (30 Days)
550.6K
1.1M
Earning Date
02-19-2026
02-05-2026
Dividend Yield
N/A
0.71%
EPS Growth
N/A
27.89
EPS
0.03
5.29
Revenue
$707,890,000.00
$5,795,600,000.00
Revenue This Year
$17.84
$11.54
Revenue Next Year
$12.44
$8.76
P/E Ratio
$6,658.81
$20.36
Revenue Growth
11.74
11.13
52 Week Low
$102.97
$90.26
52 Week High
$182.52
$127.99

Technical Indicators

Market Signals
Indicator
RGEN
EHC
Relative Strength Index (RSI) 65.21 41.31
Support Level $162.21 $103.58
Resistance Level $167.65 $108.56
Average True Range (ATR) 4.82 1.87
MACD 0.47 0.34
Stochastic Oscillator 82.67 73.28

Price Performance

Historical Comparison
RGEN
EHC

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About EHC Encompass Health Corporation

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.

Share on Social Networks: